| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385529A1 Treatment of refractory tumors using epothilone derivatives |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385522A2 Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 02/04/2004 | EP1385513A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 02/04/2004 | EP1385512A2 Use of pyridoindolone derivatives for preparing anticancer medicines |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385502A2 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
| 02/04/2004 | EP1385466A2 Oncolytic virus therapy |
| 02/04/2004 | EP1385465A2 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 02/04/2004 | EP1180024B1 Z-styryl sulfone anticancer agents |
| 02/04/2004 | EP1162985B1 Matrix protein compositions for induction of apoptosis |
| 02/04/2004 | EP1030839B1 Use of alkylated iminosugars to treat multidrug resistance |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | EP1007055B1 Use of amifostine |
| 02/04/2004 | EP0831838B1 Use of vitamin d 4 derivatives for treating skin disorders |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | EP0783326B1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473055A Methods for enhancing efficacy of cytotoxic agents through use of HSP90 inhibitors |
| 02/04/2004 | CN1473052A PSGL-1 regulator |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473041A Medical compositions for concominant use as anticancer atent |
| 02/04/2004 | CN1472319A Method of expressing thymys peptide alpha by yeast and use thereof |
| 02/04/2004 | CN1472235A Folic acid-polydiol compound and its medicinal composition |
| 02/04/2004 | CN1472226A Extractive in Taxus chinensis branches and leaves and extracting method thereof |
| 02/04/2004 | CN1472224A Holothurian extracts with anti-cancer activity and their preparation and use |
| 02/04/2004 | CN1472209A ²-carboline and sulfo-analogues subsitituted for amino-acid radical, preparing method and application thereof |
| 02/04/2004 | CN1471970A Recombination low-dosage human alpha-2b(IFN-alpha-2b) interferon lozenge and preparing method thereof |
| 02/04/2004 | CN1471967A Composition for preventing or treating tumour malignant change or tumour transfer and method thereof |
| 02/04/2004 | CN1471964A Herbal cancer eliminating granules and their preparing method |
| 02/04/2004 | CN1471927A Chinese medicine for treating alimentary system malignant tumour |
| 02/04/2004 | CN1471925A Arsenic contained composition for directly hard tumour medoicine feed, preparation, preparing method thereof |
| 02/04/2004 | CN1471908A Sesquiterpene ketone injection, preparing method and use thereof |
| 02/04/2004 | CN1137262C Mutants of Rb and P53 genes and uses thereof |
| 02/04/2004 | CN1137136C Targeted cytotoxic anthracycline analogs |
| 02/04/2004 | CN1137135C Ribosome deactivating protein originating from octagon towel gourd |
| 02/04/2004 | CN1137132C Cyanoribofuranoside compound and its preparing method |
| 02/04/2004 | CN1137130C Schizophyllum tetrasaccharide-alkyl glycoside compound and its prepn and application |
| 02/04/2004 | CN1137129C Schizophyllary tetrasaccharide cluster compound and its preparing method and use |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 02/04/2004 | CN1137087C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/04/2004 | CN1136917C TB vaccine heat reversal protein 65 and multiepi-position HER-2 Antigen fusion protein recombinat protein vaccine |
| 02/04/2004 | CN1136916C Long-acting injection suspensions and process for their preparation |
| 02/04/2004 | CN1136913C Anticancer medicine powder |
| 02/04/2004 | CN1136908C Antalgic medicine for cancerous pain and its preparing process |
| 02/04/2004 | CN1136891C Freeze dried compound queen bee powder |
| 02/04/2004 | CN1136882C Chinese medicine for treating ovarian tumor |
| 02/03/2004 | US6686484 Anticoagulants; serine protease inhibitor |
| 02/03/2004 | US6686474 Reacting benzimidazole compound with m-chloroperoxybenzoic acid in a solvent selected from the group consisting of acetone and acetone/water mixture; raising the ph of the reaction mixture; crystals are separated |
| 02/03/2004 | US6686470 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/03/2004 | US6686394 Potent antineoplastic activity without systemic toxicity or mutagenicity |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686385 Anhydro sugar derivatives of indolocarbazoles |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686380 For tumors that have initially been unresponsive to taxane therapy and developed drug resistance |
| 02/03/2004 | US6686376 Methods and compounds for inhibiting MRP1 |
| 02/03/2004 | US6686371 Having an 11h-benzo(b)fluorene, an 11h-indeno-(1,2-b) quinoline, a benz(a)anthracene or analogous skeleton and an affinity for the estrogen receptor; contraceptives; menopausal complaints, osteoporosis; antitumor agents |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686362 Indolinone derivatives |
| 02/03/2004 | US6686355 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686348 Metalloprotease inhibitors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686344 Organic-arsonic compounds |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | US6685973 Soybean extract to treat cardiovascular disorder |
| 02/03/2004 | US6685971 Oil homogenized with sterols; protective coating for stomach |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685935 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/03/2004 | US6685911 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 01/29/2004 | WO2004010146A1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009800A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009609A2 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009585A2 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009562A1 Substituted triazine kinase inhibitors |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |